What are the future trends in tablet manufacturing technology?

The future tablet production process will be upgraded around five directions: intelligence, continuity, personalization, greenness, and precise delivery. The core is to move from "batch standardization" to "flexible customization", balancing efficiency, quality, and safety. 1、 Intelligent Manufacturing and Digital Twin Introduce AI+IoT+big data throughout the entire process to achieve real-time parameter monitoring, adaptive control, and predictive maintenance. The key processes such as tablet pressing and coating are dynamically optimized by AI algorithms, and digital twin simulation production is used to reduce trial and error and waste. 2、 Continuous Manufacturing Popularization By replacing traditional batch production with technologies such as continuous direct pressing (CDC), materials can be processed from feeding to finished products in one go, resulting in reduced energy consumption, less loss, and higher batch consistency. It is expected that the proportion of continuous manufacturing production lines will significantly increase by 2030. 3、 3D/4D Printing and Personalized Production 3D printing can produce complex structures such as core-shell, multi-layer, and porous structures, achieving precise controlled release, multi drug integration, and dose customization. 4D printing further incorporates a time dimension, allowing tablets to be accurately released in response to environmental factors such as pH and temperature within the body. Hospitals/pharmacies can print on demand, suitable for children, the elderly, and rare disease patients. 4、 Green and low-carbon production Adopting solvent-free coating, biodegradable excipients, and recycled materials to reduce energy consumption and waste. Miniaturization and modularization of equipment, reducing clean area and operating costs. 5、 Accurate delivery and new excipients Nanocrystals and intelligent responsive excipients enhance the dissolution and bioavailability of insoluble drugs. Multi layer film and microfluidic controlled preparation achieve sequential release and targeted delivery, reducing side effects. 6、 Quality and Compliance Upgrades Process Analysis Technology (PAT) enables online full inspection, moving from "spot checks" to "zero defects". The data is fully traceable and meets global GMP and ICH standards.

Feb 26,2026

The future tablet production process will be upgraded around five directions: intelligence, continuity, personalization, greenness, and precise delivery. The core is to move from "batch standardization" to "flexible customization", balancing efficiency, quality, and safety.
1、 Intelligent Manufacturing and Digital Twin
Introduce AI+IoT+big data throughout the entire process to achieve real-time parameter monitoring, adaptive control, and predictive maintenance. The key processes such as tablet pressing and coating are dynamically optimized by AI algorithms, and digital twin simulation production is used to reduce trial and error and waste.
2、 Continuous Manufacturing Popularization
By replacing traditional batch production with technologies such as continuous direct pressing (CDC), materials can be processed from feeding to finished products in one go, resulting in reduced energy consumption, less loss, and higher batch consistency. It is expected that the proportion of continuous manufacturing production lines will significantly increase by 2030.
3、 3D/4D Printing and Personalized Production
3D printing can produce complex structures such as core-shell, multi-layer, and porous structures, achieving precise controlled release, multi drug integration, and dose customization. 4D printing further incorporates a time dimension, allowing tablets to be accurately released in response to environmental factors such as pH and temperature within the body. Hospitals/pharmacies can print on demand, suitable for children, the elderly, and rare disease patients.
4、 Green and low-carbon production
Adopting solvent-free coating, biodegradable excipients, and recycled materials to reduce energy consumption and waste. Miniaturization and modularization of equipment, reducing clean area and operating costs.
5、 Accurate delivery and new excipients
Nanocrystals and intelligent responsive excipients enhance the dissolution and bioavailability of insoluble drugs. Multi layer film and microfluidic controlled preparation achieve sequential release and targeted delivery, reducing side effects.
6、 Quality and Compliance Upgrades
Process Analysis Technology (PAT) enables online full inspection, moving from "spot checks" to "zero defects". The data is fully traceable and meets global GMP and ICH standards.

PREVIOUS:

What should be considered when choosing a gum base for chewing gum?

NEXT:

The Application of AI Technology in the Pharmaceutical Industry